Trials / Unknown
UnknownNCT04718272
Safety and Feasibility of the Application of Thoracic Puncture Tube After Pulmonary Lobectomy
Safety and Feasibility of the Application of Thoracic Puncture Tube VS Combination of Puncture Tube and Silicone Tube After Uniportal VATS Pulmonary Lobectomy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Fujian Medical University Union Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
There have been several reports on the feasibility of a no-drain policy after pneumonectomy, but the policy is not widely accepted because silent massive hemorrhage, delayed air leaks, and chylothorax would always be major worries for thoracic surgeons, and all of the researches were retrospective case studies with small sample size and insufficient evidence. Therefore, the purpose of this study is to to evaluate safety and feasibility of an improved policy, the application of a small thoracic puncture tube after pulmonary lobectomy.
Detailed description
This study will be accepted in patients with uniportal VATS(Video-assisted Thoracoscopic Surgery)lobetomy. A randomized controlled study protocol will be used, and The patients will be devided into two groups: experimental group for the application of a small thoracic puncture tube and control group for the application of Combination of the puncture tube and traditional silicone tube. The intraoperative conditions, postoperative recovery and the incidence of perioperative complications will be compared. The safety and feasibility of the application of the small thoracic puncture tube after pulmonary lobectomy will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | thoracic drainage management | After uniportal VATS pulmonary lobectomy, the traditional silicone tube which placed through the surgical incision was removed in the operating room in the experimental group. |
Timeline
- Start date
- 2021-01-25
- Primary completion
- 2024-04-30
- Completion
- 2024-04-30
- First posted
- 2021-01-22
- Last updated
- 2021-05-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04718272. Inclusion in this directory is not an endorsement.